2020 annual financial data
Kymera Therapeutics 2020 Net margin
Direct answer
Net margin was -133.96%.
Operating income was -46,304,000 USD and net income was -45,593,000 USD.
Operating cash flow was 88,130,000 USD.
Get free Kymera Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34,034,000 USD
- Operating income
- -46,304,000 USD
- Net income
- -45,593,000 USD
- Operating cash flow
- 88,130,000 USD